Fibroblast-activation protein is a promising target for oncologic molecular imaging. Studies
show that fibroblast activation protein inhibitor (FAPI) radiotracers are accurate diagnostics …

Fibroblast activation protein inhibitor (FAPI) is a promising tracer in oncologic positron
emission tomography/computed tomography (PET/CT). Numerous studies have …

Simple Summary Fibroblast activation protein is a newly discovered biomarker in various
tumor types. Using inhibitors ligated with radiopharmaceuticals, nuclear medicine …

Purpose 18 F-FDG is the dominant radiotracer in oncology; however, it has limitations. Novel
labeled fibroblast activation protein (FAP) radiotracers have been developed and published …

Introduction Fibroblast activation protein-α (FAPα) is overexpressed on cancer-associated
fibroblasts in approximately 90% of epithelial neoplasms, representing an appealing target …

Recently, positron emission tomography (PET) with fibroblast activation protein inhibitor
(FAPI) has gained significant attention as an advanced tumor diagnostic imaging tool. FAPI …

Fibroblast activation protein inhibitor (FAPI) PET/CT is a new tool in the diagnostic workup of
cancer. With a growing volume of applications, pitfalls and common findings need to be …

Gallium 68 (68Ga)–labeled fibroblast activation protein (FAP) inhibitor (FAPI) PET is based
on the molecular targeting of the FAP, which is known to be highly expressed in the major …

The 18F-labeled fibroblast activation protein inhibitor (FAPI)[18F] FAPI-74 has the benefit of
a higher synthetic yield and better image resolution than 68Ga-labeled FAPI. We …

Despite revolutionizing the field of oncological imaging, Positron Emission Tomography
(PET) with [18F] Fluorodeoxyglucose (FDG) as its workhorse is limited by a lack of specificity …